Alfredo Alonso
About Alfredo Alonso
Alfredo Alonso is the Oncology Business Unit Director at Bristol-Myers Squibb, with over a decade of experience in this role and a background in pharmaceutical management at GlaxoSmithKline.
Title and Role
Alfredo Alonso currently holds the title of Oncology Business Unit Director at Bristol-Myers Squibb. He has been leading this vital unit since April 2011. His responsibilities include overseeing the strategic and operational functions within the Oncology/Hematology Business Unit for the Spain and Portugal regions.
Company
Alfredo Alonso is employed at Bristol-Myers Squibb as the Oncology Business Unit Director. Bristol-Myers Squibb is a globally renowned pharmaceutical company that focuses on discovering, developing, and delivering innovative medicines for patients with serious diseases. His role has had a significant impact on the company’s operations within the oncology sector.
Previous Role at GlaxoSmithKline
Before joining Bristol-Myers Squibb, Alfredo Alonso worked at GlaxoSmithKline for 14 years. He served as Vaccines Product Manager from 1997 to 2011 in San Juan, Puerto Rico. His tenure at GlaxoSmithKline saw him take on various responsibilities related to vaccine products.
Education and Expertise
Alfredo Alonso studied at King's College, where he acquired the educational foundation that set the stage for his career in the pharmaceutical industry. His extensive experience is particularly notable in the fields of oncology and hematology, making him a seasoned expert in these areas.
Leadership and Management
Known for his transformative and innovative leadership style, Alfredo Alonso focuses on employee wellbeing while driving strategic initiatives. His approach to leadership has been instrumental in the successful management of Bristol-Myers Squibb's Oncology/Hematology Business Unit in the Spain and Portugal regions.